Yichang Humanwell Pharmaceutical Co., Ltd., China
Yichang Humanwell Pharmaceutical Co., Ltd., China
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Active, not recruiting | Phase 1 | 2026-06-30 | NCT07676357 | |
| Intravenous Hydromorphone for the Treatment of Acute Pain | Acute Chest Pain | Recruiting | Phase 1 / Phase 2 | 2025-11-17 | NCT06949059 | |
| The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial | Respiration Disorders, respiratory failure, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2025-01-21 | NCT06785571 |